KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.4252
+0.0102 (2.46%)
Feb 10, 2026, 11:39 AM EST - Market open
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $12.01 million as of February 10, 2026. Its market cap has decreased by -67.88% in one year.
Market Cap
12.01M
Enterprise Value
20.57M
1-Year Change
-67.88%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $12.01M, a decrease of -97.21%. That is a compound annual growth rate of -34.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 3.40M | -26.09% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 13.36M |
| Cadrenal Therapeutics | 13.33M |
| Curis | 13.32M |
| Moleculin Biotech | 13.27M |
| BioCardia | 13.27M |
| Cellectar Biosciences | 12.89M |
| Kairos Pharma | 12.81M |
| NewcelX | 12.63M |